title: Esophageal ulcer of Crohn's disease: disappearance in 1 week with infliximab.
authors.forename: Mitsuro
authors.initials: M
authors.lastname: Chiba
authors.forename: Takeshi
authors.initials: T
authors.lastname: Sugawara
authors.forename: Hidehiko
authors.initials: H
authors.lastname: Tsuda
authors.forename: Toru
authors.initials: T
authors.lastname: Abe
authors.forename: Takuo
authors.initials: T
authors.lastname: Tokairin
authors.forename: Yuji
authors.initials: Y
authors.lastname: Kashima
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003424:Crohn Disease / Q000150:complications / Q000188:drug therapy*; D004724:Endoscopy; D004935:Esophageal Diseases / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D000069285:Infliximab; D008297:Male; D016896:Treatment Outcome; D014456:Ulcer / Q000150:complications / Q000188:drug therapy*; D055815:Young Adult
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D000069285:Infliximab